Health In Tech Regains Compliance with Nasdaq's Minimum Bid Price Requirement

Health In Tech (NASDAQ:HIT), an Insurtech platform company, has successfully regained compliance with Nasdaq's minimum bid price requirement.

Rhea-AI Summary

Health In Tech (NASDAQ:HIT), an Insurtech platform company, has successfully regained compliance with Nasdaq's minimum bid price requirement. The company's shares maintained a closing bid price of $1.00 or higher for 10 consecutive business days from July 10 to July 23, 2025, meeting Nasdaq's Listing Rule 5550(a)(2) requirements.

Following this achievement, Nasdaq Listing Qualifications Staff has officially notified Health In Tech that they have regained compliance and the matter is now closed.

Positive

• Successfully regained Nasdaq listing compliance
• Maintained share price above $1.00 for required period
• Risk of delisting has been eliminated

Negative

• Previous trading below $1.00 indicates historical price weakness

Argus Session date unavailable

-5.15% session move Open Argus

Details

News Market Reaction – HIT

The recorded move for HIT in the trading session of this news was -5.15%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

STUART, Fla., July 24, 2025 /PRNewswire/ -- Health In Tech (Nasdaq: HIT), an Insurtech platform company backed by third-party AI technology, today announced that it received formal written confirmation from The Nasdaq Stock Market, LLC ("Nasdaq") confirming that the Company has regained compliance with Nasdaq's minimum bid price requirement.

To regain compliance with the Minimum Bid Price Requirement, the Company's common shares were required to maintain a minimum closing bid price of $1.00 or more for at least 10 consecutive business days. 

The closing bid price of the Shares has been at $1.00 per Share or greater for 10 consecutive business days from July 10 to July 23, 2025. Accordingly, Nasdaq Listing Qualifications Staff has notified the Company that it has determined that the Company has regained compliance with Nasdaq Listing Rule 5550(a)(2), and the matter is now closed.

Use of Forward‑Looking Statements

Certain statements in this press release are forward-looking statements for purposes of the safe harbor provisions under the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements may include estimates or expectations about Health In Tech's possible or assumed operational results, financial condition, business strategies and plans, market opportunities, competitive position, industry environment, and potential growth opportunities. In some cases, forward-looking statements can be identified by terms such as "may," "will," "should," "design," "target," "aim," "hope," "expect," "could," "intend," "plan," "anticipate," "estimate," "believe," "continue," "predict," "project," "potential," "goal," or other words that convey the uncertainty of future events or outcomes. These statements relate to future events or to Health In Tech's future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause Health In Tech's actual results, levels of activity, performance, or achievements to be different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements because they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond Health In Tech's control and which could, and likely will, affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects Health In Tech's current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to Health In Tech's operations, results of operations, growth strategy and liquidity.

About Health In Tech

Health In Tech (Nasdaq: "HIT") is an Insurtech platform company backed by third-party AI technology, which offers a marketplace that aims to improve processes in the healthcare industry through vertical integration, process simplification, and automation. By removing friction and complexities, we streamline the underwriting, sales and service process for insurance companies, licensed brokers, and TPAs. Learn more at healthintech.com.

Investor Contact

Investor Relations:
ir@healthintech.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/health-in-tech-regains-compliance-with-nasdaqs-minimum-bid-price-requirement-302513534.html

SOURCE Health In Tech

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What requirement did Health In Tech (HIT) meet to regain Nasdaq compliance?

Health In Tech maintained a closing bid price of $1.00 or higher for 10 consecutive business days from July 10 to July 23, 2025, meeting Nasdaq's minimum bid price requirement.

When did Health In Tech (HIT) regain Nasdaq compliance?

Health In Tech regained compliance with Nasdaq's minimum bid price requirement on July 24, 2025, after maintaining the required share price from July 10 to July 23, 2025.

What is Nasdaq's minimum bid price requirement for listed companies?

Nasdaq requires listed companies to maintain a minimum closing bid price of $1.00 per share to remain compliant with Listing Rule 5550(a)(2).

What happens now that Health In Tech (HIT) has regained Nasdaq compliance?

With compliance regained, the matter is now closed, and Health In Tech will continue its normal listing on the Nasdaq stock exchange without the risk of delisting due to minimum bid price requirements.